Skip to content

Clinical trials

Phase 3 Heart Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Phase 3 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20101
20112
20121
20131
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Amarin Pharma Inc.1
AstraZeneca1
Bayer1
CSL Behring1
Cardium Therapeutics1
Carelon Research1
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia1
Meshalkin Research Institute of Pathology of Circulation1
Vifor Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases11
Cardiovascular Diseases7
Acute Coronary Syndrome4
Coronary Artery Disease4
Angina Pectoris3
Atherosclerosis3
Coronary Disease3
Stroke3
Atrial Fibrillation2
Chest Pain2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.